Skip to main content
SpringerLink
Log in

Comment on “Prognostic Significance of FOXC1 in Various Cancers: A Systematic Review and Meta-Analysis”

  • Letter to the Editor
  • Published:
Molecular Diagnosis & Therapy Aims and scope Submit manuscript

A Letter to the Editor to this article was published on 31 October 2019

The Original Article was published on 01 August 2019

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sabapathi N, Sabarimurugan S, Madurantakam Royam M, Kumarasamy C, Xu X, Xu G, et al. Prognostic significance of FOXC1 in various cancers: a systematic review and meta-analysis. Mol Diagn Ther. 2019. https://doi.org/10.1007/s40291-019-00416-y.

    Article  PubMed  Google Scholar 

  2. Huang L, Huang Z, Fan Y, He L, Ye M, Shi K, et al. FOXC1 promotes proliferation and epithelial-mesenchymal transition in cervical carcinoma through the PI3K-AKT signal pathway. Am J Transl Res. 2017;9(3):1297–306.

    PubMed  PubMed Central  CAS  Google Scholar 

  3. Xu YL, Yao R, Li J, Zhou YD, Mao F, Pan B, et al. FOXC1 overexpression is a marker of poor response to anthracycline-based adjuvant chemotherapy in sporadic triple-negative breast cancer. Cancer Chemother Pharmacol. 2017;79(6):1205–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Weifang Medical University, Weifang, Shandong, People’s Republic of China

    Bolin Wang

  2. Department of Oncology, Affiliated Hospital of Weifang Medical University, Yuhe Road 2428, Weifang, 261031, Shandong, China

    Yan Huang

Authors
  1. Bolin Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yan Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yan Huang.

Ethics declarations

Funding

No sources of funding were used to conduct this study or prepare this letter.

Conflict of interest

Bolin Wang and Yan Huang have no conflicts of interest have no conflicts of interest that are directly relevant to the content of this letter.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, B., Huang, Y. Comment on “Prognostic Significance of FOXC1 in Various Cancers: A Systematic Review and Meta-Analysis”. Mol Diagn Ther 23, 811–812 (2019). https://doi.org/10.1007/s40291-019-00432-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40291-019-00432-y

Search

Navigation